Novel antigens in type 1 diabetes: The importance of ZnT8

Current Diabetes Reports

Volumn 9, Issue 2, 2009, Pages 105-112

  Wenzlau, Janet M ^b   Frisch, Lisa M ^b   Gardner, Thomas J ^b   Sarkar, Suparna ^b   Hutton, John C ^a   Davidson, Howard W ^b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE 65; INSULIN ANTIBODY; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG; ZINC ION; ZINC TRANSPORTER; ZINC TRANSPORTER 8; ZINC TRANSPORTER 8 ANTIBODY;

AMINO ACID SUBSTITUTION; ANTIBODY RESPONSE; AUTOIMMUNE DISEASE; CROSS REACTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPITOPE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; IMMUNOPATHOGENESIS; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ZINC DEFICIENCY;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 1; HUMANS; ZINC;

EID: 63649154970     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-009-0019-4     Document Type: Review

References (51)

1. Concannon PE Erlich HA, Julier C, et al.: Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 2005, 54: 2995-3001.
2. Erlich H, Valdes AM, Noble J, et al.: HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: Analysis of the type 1 diabetes genetics consortium families. Diabetes 2008, 57:1084-1092.
3. Kukreja A, Cost G, Marker J, et al.: Multiple immunoregulatory defects in type-1 diabetes. J Clin Invest 2002, 109:131-140.
4. Arif S, Tree TI, Astill TP, et al.: Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 2004, 113:451-463.
5. Barker JM, Barriga KJ, Yu L, et al.: Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004, 89:3896-3902.
6. Chimienti F, Devergnas S, Favier A, Seve M: Identification and cloning of a beta-cell-specific zinc transporter, ZnT8, localized into insulin secretory granules. Diabetes 2004, 53:2330-2337.
7. Wenzlau JM, Juhl K, Yu L, et al.: The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007, 104:17040-17045.
8. Palmer JP, Asplin CM, Clemons P, et al.: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983, 222:1337-1339.
9. Baekkeskov S, Aanstoot HJ, Christgau S, et al.: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990, 347:151-156.
10. Rabin DU, Pleasic SM, Palmer-Crocker R, Shapiro JA: Cloning and expression of IDDM-specific human autoantigens. Diabetes 1992, 41:183-186.
11. Bonifacio E, Lampasona V, Genovese S, et al.: Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 1995, 155:5419-5426.
12. Arden SD, Zahn T, Steegers S, et al.: Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes 1999, 48:531-542.
13. Lieberman SM, Evans AM, Han B, et al.: Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci U S A 2003, 100:8384-8388.
14. Su AI, Wiltshire T, Batalov S, et al.: A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 2004, 101:6062-6067.
15. Juhl K, Sarkar SA, Wong R, et al.: Mouse pancreatic endocrine cell transcriptome defined in the embryonic Ngn3-null mouse. Diabetes 2008, 57:2755-2761.
16. Gyulkhandanyan AV, Lu H, Lee SC, et al.: Investigation of transport mechanisms and regulation of intracellular Zn2+ in pancreatic alpha-cells. J Biol Chem 2008, 283:10184-10197.
17. Cousins RJ, McMahon RJ: Integrative aspects of zinc transporters. J Nutr 2000, 130(5SSuppl): 1384S-1387S.
18. Aydemir TB, Blanchard RK, Cousins RJ: Zinc supplementation of young men alters metallothionein, zinc transporter, and cytokine gene expression in leukocyte populations. Proc Natl Acad Sci U S A 2006, 103:1699-1704.
19. Andrews GK, Wang H, Dey SK, Palmiter RD: Mouse zinc transporter 1 gene provides an essential function during early embryonic development. Genesis 2004, 40:74-81.
20. Dufner-Beattie J, Weaver BP, Geiser J, et al.: The mouse acrodermatitis enteropathica gene Slc39a4 (Zip4) is essential for early development and heterozygosity causes hypersensitivity to zinc deficiency. Hum Mol Genet 2007, 16:1391-1399.
21. Huang L, Gitschier J: A novel gene involved in zinc transport is deficient in the lethal milk mouse. Nat Genet 1997, 17:292-297.
22. Andrews GK: Regulation and function of Zip4, the acrodermatitis enteropathica gene. Biochem Soc Trans 2008, 36(Pt 6): 1242-1246.
23. Huang L, Yu YY, Kirschke CP, et al.: Znt7 (Slc30a7)-deficient mice display reduced body zinc status and body fat accumulation. J Biol Chem 2007, 282:37053-37063.
24. Cole TB, Robbins CA, Wenzel HJ, et al.: Seizures and neuronal damage in mice lacking vesicular zinc. Epilepsy Res 2000, 39:153-169.
25. Kambe T, Geiser J, Lahner B, et al.: Slc39a1 to 3 (subfamily II) Zip genes in mice have unique cell-specific functions during adaptation to zinc deficiency. Am J Physiol Regul Integr Comp Physiol 2008, 294:R1474-R1481.
26. Dufner-Beattie J, Huang ZL, Geiser J, et al.: Mouse ZIP1 and ZIP3 genes together are essential for adaptation to dietary zinc deficiency during pregnancy. Genesis 2006, 44:239-251.
27. Franklin I, Gromada J, Gjinovci A, et al.: Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes 2005, 54:1808-1815.
28. Zhou H, Zhang T, Harmon JS, et al.: Zinc, not insulin, regulates the rat alpha-cell response to hypoglycemia in vivo. Diabetes 2007, 56:1107-1112.
29. Chimienti F, Favier A, Seve M: ZnT8, a pancreatic betacell-specific zinc transporter. Biometals 2005, 18:313-317.
30. Quarterman J, Florence E: Observations on glucose tolerance and plasma levels of free fatty acids and insulin in the zincdeficient rat. Br J Nutr 1972, 28:75-79.
31. Boquist L, Lernmark A: Effects on the endocrine pancreas in Chinese hamsters fed zinc deficient diets. Acta Pathol Microbiol Scand 1969, 76:215-228.
32. Ravier MA, Rutter GA: Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells. Diabetes 2005, 54:1789-1797.
33. Haase H, Ober-Blobaum JL, Engelhardt G, et al.: Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes. J Immunol 2008, 181:6491-6502.
34. Yamasaki S, Sakata-Sogawa K, Hasegawa A, et al.: Zinc is a novel intracellular second messenger. J Cell Biol 2007, 177:637-645.
35. Eisenbarth SC, Colegio OR, OConnor W, et al.: Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008, 453:1122-1126.
36. Fontenot AP, Falta MT, Freed BM, et al.: Identification of pathogenic T cells in patients with beryllium-induced lung disease. J Immunol 1999, 163:1019-1026.
37. Amicosante M, Fontenot AP: T cell recognition in chronic beryllium disease. Clin Immunol 2006, 121:134-143.
38. Yu L, Cuthbertson DD, Maclaren N, et al.: Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1. Diabetes 2001, 50:1735-1740.
39. Bingley PJ, Bonifacio E, Mueller PW: Diabetes Antibody Standardization Program: First assay proficiency evaluation. Diabetes 2003, 52:1128-1136.
40. Mayr A, Schlosser M, Grober N, et al.: GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes. Diabetes 2007, 56:1527-1533.
41. Williams AJ, Aitken RJ, Chandler MA, et al.: Autoantibodies to islet antigen-2 are associated with HLA-DRB1* 07 and DRB1* 09 haplotypes as well as DRB1* 04 at onset of type 1 diabetes: The possible role of HLA-DQA in autoimmunity to IA-2. Diabetologia 2008, 51:1444-1448.
42. Solimena M, Folli F, Denis-Donini S, et al.: Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 1988, 318:1012-1020.
43. Lu M, Fu D: Structure of the zinc transporter YiiP. Science 2007, 317:1746-1748.
44. Boesgaard TW, Zilinskaite J, Vanttinen M, et al.: The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients-the EUGENE2 study. Diabetologia 2008, 51:816-820.
45. Kawasaki E, Uga M, Nakamura K, et al.: Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia 2008, 51:2299-2302.
46. Wenzlau JM, Liu Y, Yu L, et al.: A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 2008, 57:2693-2697.
47. Gohlke H, Ferrari U, Koczwara K, et al.: SLC30A8 (ZnT8) polymorphism is associated with young age at type 1 diabetes onset. Rev Diabet Stud 2008, 5:25-27.
48. Sladek R, Rocheleau G, Rung J, et al.: A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
49. Zeggini E, Weedon MN, Lindgren CM, et al.: Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341.
50. Chimienti F, Wheeler MB, Nicholson TJ, et al.: Single nucleotide polymorphism rs13266634 modifies the Zn transporter activity of SLC30A8/ ZnT8 in clonal pancreatic beta cells. Diabetologia 2008, Suppl 1:S47.
51. Scheuner D, Kaufman RJ: TAe unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes. Endocr Rev 2008, 29:317-333.